Loading ETF profile…

This fund strategically invests in a combination of financial instruments, chosen by ProShare Advisors, with the goal of emulating its underlying benchmark's performance. That benchmark endeavors to replicate the risk and return profile typical of the hedge fund asset class, which it achieves by seeking a high correlation to the HFRI Fund Weighted Composite Index (HFRI). The HFRI itself serves as a gauge of the hedge fund industry's overall performance, comprising an equally weighted composite of over 2,000 member funds. This particular fund is categorized as non-diversified.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| — | TREASURY BILL | 66.34% | $14.27M |
| — | Net Other Assets (Liabilities) | 19.59% | $4.21M |
| — | MOOG INC-CLASS A | 0.05% | $10.96K |
| BTSG | BRIGHTSPRING HEALTH SERVICES | 0.05% | $10.94K |
| CYTK | CYTOKINETICS INC | 0.05% | $10.41K |
| UMBF | UMB FINANCIAL CORP | 0.05% | $10.13K |
| HUT | HUT 8 CORP | 0.05% | $9.73K |
| FROG | JFROG LTD | 0.04% | $9.57K |
| CTRE | CARETRUST REIT INC | 0.04% | $8.87K |
| ONB | OLD NATIONAL BANCORP | 0.04% | $8.84K |
| VSAT | VIASAT INC | 0.04% | $8.52K |
| KRYS | KRYSTAL BIOTECH INC | 0.04% | $8.49K |
| FCFS | FIRSTCASH HOLDINGS INC | 0.04% | $8.40K |
| GKOS | GLAUKOS CORP | 0.04% | $8.38K |
| CRNX | CRINETICS PHARMACEUTICALS IN | 0.04% | $8.37K |
| ALKS | ALKERMES PLC | 0.04% | $8.31K |
| ESE | ESCO TECHNOLOGIES INC | 0.04% | $8.14K |
| COMP | COMPASS INC - CLASS A | 0.04% | $8.07K |
| AGX | ARGAN INC | 0.04% | $8.07K |
| SNEX | STONEX GROUP INC | 0.04% | $7.93K |
| PRAX | PRAXIS PRECISION MEDICINES I | 0.04% | $7.86K |
| JXN | JACKSON FINANCIAL INC-A | 0.04% | $7.80K |
| EAT | BRINKER INTERNATIONAL INC | 0.04% | $7.78K |
| HQY | HEALTHEQUITY INC | 0.04% | $7.75K |
| PTGX | PROTAGONIST THERAPEUTICS INC | 0.04% | $7.74K |